[New options in the therapeutic management of acute ischaemic stroke. Good results with combined i. v. and i. a. lysis and mechanical thrombectomy]

Fortschr Neurol Psychiatr. 2010 Nov;78(11):652-7. doi: 10.1055/s-0029-1245582. Epub 2010 Nov 10.
[Article in German]

Abstract

Background: Standard therapy for acute ischaemic stroke is the intravenous thrombolysis with rtPA. A combined therapy with intravenous bridging and consecutive intraarterial thrombolysis and mechanical thrombectomy is a relatively new option in patients with proximal vessel occlusion.

Patients and methods: 10 Patients with a CTA proven proximal vessel occlusion in the anterior circulation (ACI, carotis bifurcation, MCA) in CTA were treated with a combined therapy with i. v. and i. a. thrombolysis and thrombectomy with a Solitaire FR stent device.

Results: All Patients were recanalized, the NIHSS changed from 15.6 to 3.3. 8 out of 10 patients had nearly no symptoms when dismissed. There were no direct therapeutic complications.

Conclusion: Combined therapy with i. v. and i. a. thrombolysis and thombectomy with the Solitaire FR stent device is a promising option in patients with acute proximal vessel occlusion in the anterior circulation.

Publication types

  • English Abstract

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Aspirin / therapeutic use
  • Brain Ischemia / complications
  • Brain Ischemia / therapy*
  • Carotid Artery Diseases / drug therapy
  • Carotid Artery Diseases / therapy
  • Cerebral Angiography
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Infarction, Middle Cerebral Artery / drug therapy
  • Infarction, Middle Cerebral Artery / therapy
  • Injections, Intra-Arterial
  • Injections, Intravenous
  • Magnetic Resonance Angiography
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / therapeutic use
  • Stents
  • Stroke / etiology
  • Stroke / therapy*
  • Thrombectomy*
  • Thrombolytic Therapy / methods*
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Tissue Plasminogen Activator
  • Aspirin